467
edits
Infective Endocarditis: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 43: | Line 43: | ||
===Definite IE:=== | ===Definite IE:=== | ||
*Pathologic Criteria: | *Pathologic Criteria: | ||
**Microorganisms demonstrated by culture or histologic examination of vegetation, a vegetation that has embolized, or an intracardiac abscess specimen OR pathologic lesions; vegetation or intracardiac abscess confirmed by histologic examination showing active endocarditis | **Microorganisms demonstrated by culture or histologic examination of vegetation, a vegetation that has embolized, or an intracardiac abscess specimen OR pathologic lesions; vegetation or intracardiac abscess confirmed by histologic examination showing active endocarditis | ||
| Line 50: | Line 49: | ||
===Possible IE:=== | ===Possible IE:=== | ||
*1 Major criterion + 1 Minor criterion '''OR''' 3 minor criteria | *1 Major criterion + 1 Minor criterion '''OR''' 3 minor criteria | ||
===Rejected IE:=== | ===Rejected IE:=== | ||
*Firm alternate diagnosis explaining evidence of IE '''OR''' | *Firm alternate diagnosis explaining evidence of IE '''OR''' | ||
*Resolution of IE syndrome with =<4 days of antibiotics therapy '''OR''' | *Resolution of IE syndrome with =<4 days of antibiotics therapy '''OR''' | ||
| Line 135: | Line 132: | ||
[http://eurheartj.oxfordjournals.org/content/30/19/2369.long The guidelines on treatment of endocarditis from the task force for treatment of Infective endocarditis of the European Society of Cardiology shows this.] | [http://eurheartj.oxfordjournals.org/content/30/19/2369.long The guidelines on treatment of endocarditis from the task force for treatment of Infective endocarditis of the European Society of Cardiology shows this.] | ||
===Prophylaxis=== | ===Prophylaxis=== | ||
According the American Heart Association guidelines published in 2007 the following groups of patients are considered to be high-risk and require prophylaxis:<cite>xvii</cite> | According the American Heart Association guidelines published in 2007 the following groups of patients are considered to be high-risk and require prophylaxis:<cite>xvii</cite> | ||